ClinicalTrials.gg
CompletedNCT07926555PERTUpdated Nov 9, 2026

The PERT Study - Training Factors of PERformance and Injuries

An observational study in Athletic Injuries (C26.857.500.124), sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to male participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by University Hospital, Clermont-Ferrand · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
77
Sex
Male
01

Study summary

The goal of this observational study was to learn about injuries in professional football players and to find out whether daily monitoring data could help predict injuries. The study followed male players from the first team and the reserve team of a French first-division professional football club over one full competitive season.

The main questions were:

How often did injuries occur among players over the season? Which day-to-day changes in routinely monitored data were linked to the onset of a new injury (all injuries combined, intrinsic and extrinsic)? Were the results similar when looking only at intrinsic injuries?

Each day, the club's staff recorded each player's physical workload during training sessions and matches using tracking technology. Players also reported how they felt, including sleep, fatigue, mood, and pain. New injuries were recorded daily by the club's medical staff. Players took part through the club's usual daily monitoring, with no additional tests or visits.

02

Conditions studied

  • Athletic Injuries (C26.857.500.124)

Browse trials for

Keywords

  • Training load
  • Injury risk
  • Injury prediction
  • Workload monitoring
  • Self-reported pain
  • Professional football
  • Professional sport
  • Intrinsic injuries
03

In context

Athletic Injuries

258 studies on the registry are indexed under Athletic Injuries; 45 are open to participants now.

This study's enrollment of 77 is below the median of 100 across 91 observational studies indexed under Athletic Injuries.

Browse Athletic Injuries studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 179 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Male football players from the first team and the reserve team of a French first-division professional football club, followed over one full competitive season.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male football players belonging to the first team or the reserve team of the participating French first-division professional football club during the study season

Exclusion criteria

Exclusion Criteria:

  • Fewer than 20 days of available monitoring data during the season
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
77 participants (actual)
Patient registry
No

Groups and cohorts

  • Professional football players

    Male players from the first team and the reserve team of a French first-division professional football club, followed daily over one full competitive season through the club's routine monitoring of external workload, self-reported wellness and injury status.

    Other: Routine daily monitoring

Interventions

  • OtherRoutine daily monitoring

    No intervention was assigned. Data came from the club's usual daily monitoring: external workload measured by tracking technology during training sessions and matches, and self-reported sleep, fatigue, mood, pain and perceived intensity.

06

What researchers measure

Primary outcomes

  1. Injury prevalence and occurrence of new injuries

    Daily injury status (non-injured or injured) recorded by the club's medical staff, used to describe season-long injury prevalence.

    Time frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

  2. Player characteristics

    Age (years), professional status (reserve team or professional), playing position (defender, midfielder or forward) and number of previous injuries (0, 1 or ≥2), examined as putative factors associated with injury occurrence.

    Time frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

  3. External workload

    Measured by tracking technology during training sessions and matches: match exposure (yes or no), session duration (minutes), total distance covered (km), number of accelerations and decelerations per day, distance covered (m) and number of sprints per day at 80-90% and 90-100% of each player's individual maximal speed. Examined as putative factors associated with injury occurrence.

    Time frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

  4. Self-reported wellness and perceived exertion

    Sleep time (hours/day), sleep quality (1 = best to 7 = worst), mood (1 = best to 7 = worst), fatigue (1 = min to 7 = max), pain (1 = min to 7 = max) and perceived exertion (1 = min to 10 = max). Examined as putative factors associated with injury occurrence.

    Time frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

07

Study locations

1 site
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07926555
Responsible party
Sponsor
First posted
Nov 9, 2026
Start date
Jul 1, 2024
Primary completion
May 30, 2025
Completion
May 30, 2025
Last update
Nov 9, 2026

Study contacts

Frédéric Dutheil
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion